Latest in News & Research
Metabolic Syndrome, Circadian Syndrome Linked to Melanoma Risk
Stronger associations seen in men; risk for melanoma increases sharply when more than two components of MetS present in men
Risk for Serious Infection Up With Adalimumab Use in Hidradenitis Suppurativa Versus Psoriasis
Patients with hidradenitis suppurativa have increased likelihood of sepsis, genitourinary infection versus those with psoriasis
High Response to PD-1 Therapy Seen in Unresectable Desmoplastic Melanoma
Complete response rate was 37 percent, and post-hoc end point of objective response rate was 89 percent
Potential Benefits Seen for GLP-1 RAs in Hidradenitis Suppurativa Management
At six months, 50 to 60 percent of patients achieved a 1-point or higher reduction in HS Physician's Global Assessment
Patients With Obesity More Likely to Be Diagnosed With Earlier-Stage Melanoma
Individuals with obesity and serious comorbidities significantly more likely to have earlier T-stage at diagnosis
Lebrikizumab Efficacious, Safe for Patients With Skin of Color, Eczema
64.4 percent of patients with postinflammatory hyperpigmented lesions at baseline experienced reduced hyperpigmentation at week 24
Public Believes Dermatologic Side Effects From Cancer Treatment Are Common
Findings seen among both those previously treated for cancer and cancer-naive people
Firefighters Face Elevated Mortality Rates for Skin and Kidney Cancer
Suggestive increases for prostate and colorectal cancer mortality observed with more years as a firefighter
Researchers Identify Risk Thresholds Using 40-GEP to Manage Decisions for cSCC
40-gene expression profiling can inform adjuvant radiation therapy and surveillance imaging decision-making
Interclass Biologic Switching Effective for Patients With Psoriasis
Highest risk for infection associated with switching from anti-TNF-α to anti-IL-23p19, anti-IL-17A, anti-IL-12/23p40
LAUNCH ALERT: FDA Approves Anzupgo (Delgocitinib) Cream for Moderate-to-Severe Chronic Hand Eczema in Adults
The topical pan-JAK inhibitor is the first FDA-approved therapy specifically indicated for chronic hand eczema
40-Gene Expression Profile Predicts Local Recurrence in High-Risk cSCC
Three-year local recurrence-free survival, metastasis-free survival higher for class 1 versus class 2A or 2B patients
Risk for New-Onset Depression, Anxiety Elevated for Patients With Hidradenitis Suppurativa
No consistent differences seen across severity levels using treatment and HS-related surgical procedures as markers of severity
FDA Approves First Cream for Treating Chronic Hand Eczema
Key Takeaways
- The U.S. Food and Drug Administration has given its nod to a new treatment for chronic hand eczema
- Anzupgo is now the...
Alopecia Areata Associated With Severe Psychosocial Impact
High levels of anxiety, depression, stigma, and impaired QoL reported by many patients; all linked to perceptions of illness
Novel Treatments Recommended for Management of Atopic Dermatitis in Adults
Strong recommendations presented for tapinarof cream, roflumilast cream, lebrikizumab, nemolizumab with concomitant topical therapy
Daily Emollient Application May Reduce Risk for Atopic Dermatitis in Infants
Daily emollient applications starting before age 9 weeks linked to reduction in cumulative incidence of atopic dermatitis at age 24 months
Factors Identified That Affect Dermoscopic Findings in Acral Melanoma
Tumor thickness, lesion diameter, patient sex, and patient age may affect dermoscopic findings
Study Compares Benefits, Harms of Treatments for Chronic Hives
Systematic review and network meta-analysis included 93 trials evaluating 42 interventions
Subclinical Synovitis Risk Higher in Psoriasis Without Musculoskeletal Involvement
Authors say imaging may aid in identifying individuals at risk for progression to psoriatic arthritis
Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma
80 percent of adult patients with stage III/IV resectable melanoma remained event-free at four years from the start of neoadjuvant systemic treatment
Number of Atopic Dermatitis Flares Linked to Lower QoL, More Severe Disease
Flare severity, duration, and number were among most important predictors of AD severity
Neutrophil-to-Lymphocyte Ratio Can ID Risk in Localized Melanoma
NLR level >4.8 associated with increased risk for melanoma-specific death and developing distant metastases
24 of 1238